Abscess volume as a predictor of surgical intervention in children hospitalized with orbital cellulitis: A multicentre cohort study.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 11 03 2023
revised: 04 06 2023
accepted: 07 06 2023
medline: 26 7 2023
pubmed: 13 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

Orbital cellulitis with subperiosteal or orbital abscess can result in serious morbidity and mortality in children. Objective volume criterion measurement on cross-sectional imaging is a useful clinical tool to identify patients with abscess who may require surgical drainage. To determine the predictive value of abscess volume and the optimal volume cut-point for surgical intervention. We conducted an observational cohort study using medical records from children hospitalized between 2009 and 2018. Multicentre study using data from 6 children's hospitals. Children were included if they were between 2 months and 18 years of age and hospitalized for an orbital infection with an abscess confirmed on cross-sectional imaging. Subperiosteal or orbital abscess volume. The primary outcome was surgical intervention, defined as subperiosteal and/or orbital abscess drainage. Multivariable logistic regression was performed to assess the association of abscess volume with surgery. To determine the optimal abscess volume cut-point, receiver operating characteristic (ROC) analysis was performed using the Youden Index to optimize sensitivity and specificity. Of the 150 participants (mean [SD] age, 8.5 [4.5] years), 68 (45.3%) underwent surgical intervention. On multivariable analysis, larger abscess volume and non-medial abscess location were associated with surgical intervention (abscess volume: adjusted odds ratio [aOR], 1.46; 95% CI, 1.11-1.93; abscess location: aOR, 3.46; 95% CI, 1.4-8.58). ROC analysis demonstrated an optimal abscess volume cut-point of 1.18 mL [AUC: 0.75 (95% CI 0.67-0.83) sensitivity: 66%; specificity: 79%]. CONCLUSIONS AND RELEVANCE: In this multicentre cohort study of 150 children with subperiosteal or orbital abscess, larger abscess volume and non-medial abscess location were significant predictors of surgical intervention. Children with abscesses >1.18 mL should be considered for surgery.

Identifiants

pubmed: 37437497
pii: S0165-5876(23)00196-9
doi: 10.1016/j.ijporl.2023.111629
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Multicenter Study Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111629

Investigateurs

Peter J Gill (PJ)
Eleanor Pullenayegum (E)
Patricia C Parkin (PC)
Elysa Widjaja (E)
Arun Reginald (A)
Nikolaus E Wolter (NE)
Sanjay Mahant (S)
Semipe Oni (S)
Rashid Anwar (R)
Jessica Cichon (J)
Olivier Drouin (O)
Hossam Louriachi (H)
Catherine Pound (C)
Julie Quet (J)
Carsten Krueger (C)
Yipeng Ge (Y)
Nardin Kirolos (N)
Gita Wahi (G)
Ashaka Patel (A)
Ann Bayliss (A)
Hardika Jasani (H)
Emily Kornelsen (E)
Gemma Vomiero (G)
Ashton Chugh (A)
Jessica L Foulds (JL)
Sandra Gouda (S)
Ronik Kanani (R)
Susan Akbaroghli (S)
Anupam Sehgal (A)
Morgyn F McKerlie (MF)
Peter J Gill (PJ)
Olivier Drouin (O)
Catherine Pound (C)
Julie Quet (J)
Gita Wahi (G)
Ann Bayliss (A)
Gemma Vomiero (G)
Jessica Foulds (J)
Ronik Kanani (R)
Mahmoud Sakran (M)
Anupam Sehgal (A)
Sanjay Mahant (S)

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest PJG has received grants from the Canadian Institutes of Health Research (CIHR), the PSI Foundation, and The Hospital for Sick Children. He has received nonfinancial support from the EBMLive Steering Committee (expenses reimbursed to attend conferences) and the CIHRInstitute of Human Development, Child and Youth Health (as a member of the institute advisory board, expenses reimbursed to attend meetings). He is a member of the CMAJ Open and BMJ Evidence Based Medicine Editorial Board. PCP has received grants from the Hospital for Sick ChildrenFoundation (SP05-602), Canadian Institutes of Health Research (FRN # 115059), and non-financial support for an investigator-initiated trial for which Mead Johnson Nutrition provides non-financial support (Fer-In-Sol® liquid iron supplement) (2011–2017). OD was supported by a Chercheur Boursier Clinicien Award, from the Fonds de recherche du Québec – Santé. GW has received grants from the Canadian Institutes of Health Research and the Hamilton Health SciencesFoundation.

Auteurs

Morgyn F McKerlie (MF)

Queens School of Medicine, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.

Nikolaus E Wolter (NE)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Otolaryngology, Head & Neck Surgery, University of Toronto, Toronto, ON, Canada.

Sanjay Mahant (S)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Jessica Cichon (J)

Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada.

Elysa Widjaja (E)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada.

Olivier Drouin (O)

Department of Pediatrics, Université de Montreal, Montreal, QC, Canada; Division of General Pediatrics, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada; Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, QC, Canada.

Catherine Pound (C)

Department of Pediatrics, University of Ottawa, Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada.

Julie Quet (J)

Department of Pediatrics, University of Ottawa, Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, Canada.

Gita Wahi (G)

Department of Pediatrics, McMaster University, McMaster Children's Hospital, Hamilton, ON, Canada.

Ann Bayliss (A)

Trillium Health Partners, Department of Paediatrics, University of Toronto, Mississauga, ON, Canada.

Gemma Vomiero (G)

Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada.

Jessica L Foulds (JL)

Department of Pediatrics, University of Alberta, Stollery Children's Hospital, Edmonton, AB, Canada.

Ronik Kanani (R)

North York General Hospital, University of Toronto, Toronto, ON, Canada.

Mahmoud Sakran (M)

Department of Paediatrics, Queens University, Lakeridge Health, Oshawa, ON, Canada; Research, Lakeridge Health, Oshawa, ON, Canada.

Anupam Sehgal (A)

Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada.

Cornelia M Borkhoff (CM)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Eleanor Pullenayegum (E)

Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Arun Reginald (A)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, ON, Canada.

Patricia C Parkin (PC)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Peter J Gill (PJ)

The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, University of Toronto, Toronto, ON, Canada; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada. Electronic address: peter.gill@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH